Annual EBIT
-$8.52 M
-$19.19 M-179.93%
31 December 2023
Summary:
TherapeuticsMD annual earnings before interest & taxes is currently -$8.52 million, with the most recent change of -$19.19 million (-179.93%) on 31 December 2023. During the last 3 years, it has risen by +$148.95 million (+94.59%). TXMD annual EBIT is now -179.93% below its all-time high of $11.86 million.TXMD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$564.00 K
+$481.00 K+46.03%
30 September 2024
Summary:
TherapeuticsMD quarterly earnings before interest & taxes is currently -$564.00 thousand, with the most recent change of +$481.00 thousand (+46.03%) on 30 September 2024. Over the past year, it has increased by +$850.00 thousand (+60.11%). TXMD quarterly EBIT is now -100.97% below its all-time high of $58.04 million, reached on 31 December 2022.TXMD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$4.90 M
+$850.00 K+14.79%
30 September 2024
Summary:
TherapeuticsMD TTM earnings before interest & taxes is currently -$4.90 million, with the most recent change of +$850.00 thousand (+14.79%) on 30 September 2024. Over the past year, it has dropped by -$56.90 million (-109.42%). TXMD TTM EBIT is now -109.42% below its all-time high of $52.00 million, reached on 30 September 2023.TXMD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -179.9% | +60.1% | -109.4% |
| 3 y3 years | +94.6% | +98.6% | +96.6% |
| 5 y5 years | +93.3% | +97.9% | +96.8% |
TXMD EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -179.9% | +94.6% | -101.0% | +98.6% | -109.4% | +96.6% |
| 5 y | 5 years | -179.9% | +94.7% | -101.0% | +98.9% | -109.4% | +97.2% |
| alltime | all time | -179.9% | +94.7% | -101.0% | +98.9% | -109.4% | +97.2% |
TherapeuticsMD EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$564.00 K(-46.0%) | -$4.90 M(-14.8%) |
| June 2024 | - | -$1.04 M(+29.2%) | -$5.75 M(-18.7%) |
| Mar 2024 | - | -$809.00 K(-67.4%) | -$7.07 M(-17.0%) |
| Dec 2023 | -$8.52 M(-179.9%) | -$2.48 M(+75.4%) | -$8.52 M(-116.4%) |
| Sept 2023 | - | -$1.41 M(-40.3%) | $52.00 M(+34.1%) |
| June 2023 | - | -$2.37 M(+4.8%) | $38.78 M(+47.6%) |
| Mar 2023 | - | -$2.26 M(-103.9%) | $26.28 M(+146.4%) |
| Dec 2022 | $10.66 M(-113.4%) | $58.04 M(-496.7%) | $10.66 M(-157.1%) |
| Sept 2022 | - | -$14.63 M(-1.6%) | -$18.68 M(-58.9%) |
| June 2022 | - | -$14.87 M(-16.8%) | -$45.43 M(-32.2%) |
| Mar 2022 | - | -$17.88 M(-162.3%) | -$67.02 M(-15.8%) |
| Dec 2021 | -$79.58 M(-49.5%) | $28.70 M(-169.3%) | -$79.58 M(-44.6%) |
| Sept 2021 | - | -$41.38 M(+13.5%) | -$143.63 M(+12.1%) |
| June 2021 | - | -$36.47 M(+19.8%) | -$128.14 M(-6.2%) |
| Mar 2021 | - | -$30.43 M(-14.0%) | -$136.62 M(-12.9%) |
| Dec 2020 | -$157.47 M(-1.3%) | -$35.36 M(+36.6%) | -$156.78 M(-5.6%) |
| Sept 2020 | - | -$25.89 M(-42.4%) | -$166.05 M(-0.3%) |
| June 2020 | - | -$44.95 M(-11.1%) | -$166.53 M(-3.6%) |
| Mar 2020 | - | -$50.59 M(+13.4%) | -$172.79 M(+8.3%) |
| Dec 2019 | -$159.62 M(+24.8%) | -$44.63 M(+69.2%) | -$159.62 M(+4.8%) |
| Sept 2019 | - | -$26.37 M(-48.5%) | -$152.29 M(-4.5%) |
| June 2019 | - | -$51.21 M(+36.9%) | -$159.47 M(+13.1%) |
| Mar 2019 | - | -$37.42 M(+0.3%) | -$140.95 M(+10.2%) |
| Dec 2018 | -$127.94 M(+66.3%) | -$37.30 M(+11.2%) | -$127.94 M(+14.2%) |
| Sept 2018 | - | -$33.55 M(+2.6%) | -$112.07 M(+20.3%) |
| June 2018 | - | -$32.69 M(+34.0%) | -$93.18 M(+16.2%) |
| Mar 2018 | - | -$24.40 M(+13.9%) | -$80.17 M(+4.0%) |
| Dec 2017 | -$76.93 M(-14.4%) | -$21.43 M(+46.1%) | -$77.06 M(-1.5%) |
| Sept 2017 | - | -$14.66 M(-25.5%) | -$78.19 M(-11.8%) |
| June 2017 | - | -$19.68 M(-7.6%) | -$88.65 M(-1.7%) |
| Mar 2017 | - | -$21.29 M(-5.7%) | -$90.19 M(+0.3%) |
| Dec 2016 | -$89.88 M(+5.5%) | -$22.56 M(-10.2%) | -$89.88 M(+6.0%) |
| Sept 2016 | - | -$25.13 M(+18.5%) | -$84.82 M(+7.1%) |
| June 2016 | - | -$21.21 M(+1.1%) | -$79.20 M(-7.1%) |
| Mar 2016 | - | -$20.97 M(+19.8%) | -$85.24 M(+0.1%) |
| Dec 2015 | -$85.19 M(+57.9%) | -$17.51 M(-10.2%) | -$85.19 M(+1.4%) |
| Sept 2015 | - | -$19.50 M(-28.4%) | -$83.98 M(+2.0%) |
| June 2015 | - | -$27.26 M(+30.3%) | -$82.31 M(+24.8%) |
| Mar 2015 | - | -$20.92 M(+28.3%) | -$65.96 M(+22.2%) |
| Dec 2014 | -$53.96 M(+109.5%) | -$16.30 M(-8.6%) | -$53.96 M(+18.2%) |
| Sept 2014 | - | -$17.83 M(+63.6%) | -$45.64 M(+30.3%) |
| June 2014 | - | -$10.90 M(+22.1%) | -$35.03 M(+17.8%) |
| Mar 2014 | - | -$8.92 M(+11.8%) | -$29.74 M(+15.4%) |
| Dec 2013 | -$25.75 M(-22.5%) | -$7.98 M(+10.5%) | -$25.77 M(+12.1%) |
| Sept 2013 | - | -$7.22 M(+28.7%) | -$22.99 M(+15.6%) |
| June 2013 | - | -$5.61 M(+13.5%) | -$19.89 M(-20.4%) |
| Mar 2013 | - | -$4.95 M(-5.0%) | -$24.97 M(-24.8%) |
| Dec 2012 | -$33.21 M(+158.5%) | -$5.21 M(+26.4%) | -$33.21 M(-11.5%) |
| Sept 2012 | - | -$4.12 M(-61.5%) | -$37.55 M(+7.6%) |
| June 2012 | - | -$10.70 M(-18.9%) | -$34.90 M(+38.1%) |
| Mar 2012 | - | -$13.19 M(+38.3%) | -$25.26 M(+96.6%) |
| Dec 2011 | -$12.85 M | -$9.54 M(+548.7%) | -$12.85 M(+117.2%) |
| Sept 2011 | - | -$1.47 M(+37.9%) | -$5.91 M(+31.1%) |
| June 2011 | - | -$1.07 M(+37.7%) | -$4.51 M(+28.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$774.40 K(-70.3%) | -$3.51 M(+22.5%) |
| Dec 2010 | -$2.87 M(+74.2%) | -$2.60 M(+3792.1%) | -$2.87 M(+222.4%) |
| Sept 2010 | - | -$66.90 K(+0.3%) | -$889.40 K(-24.2%) |
| June 2010 | - | -$66.70 K(-48.7%) | -$1.17 M(+4.7%) |
| Mar 2010 | - | -$130.00 K(-79.2%) | -$1.12 M(+9.9%) |
| Dec 2009 | -$1.65 M(+316.0%) | -$625.80 K(+78.3%) | -$1.02 M(+153.3%) |
| Sept 2009 | - | -$350.90 K(+2371.1%) | -$402.60 K(+310.0%) |
| June 2009 | - | -$14.20 K(-51.0%) | -$98.20 K(-74.8%) |
| Mar 2009 | - | -$29.00 K(+241.2%) | -$389.50 K(-1.5%) |
| Dec 2008 | -$395.60 K(+322.2%) | -$8500.00(-81.7%) | -$395.60 K(-3.8%) |
| Sept 2008 | - | -$46.50 K(-84.8%) | -$411.20 K(+4.5%) |
| June 2008 | - | -$305.50 K(+770.4%) | -$393.50 K(+261.0%) |
| Mar 2008 | - | -$35.10 K(+45.6%) | -$109.00 K(+16.5%) |
| Dec 2007 | -$93.70 K(-30.7%) | -$24.10 K(-16.3%) | -$93.60 K(-84.7%) |
| Sept 2007 | - | -$28.80 K(+37.1%) | -$610.40 K(+72.4%) |
| June 2007 | - | -$21.00 K(+6.6%) | -$354.00 K(+53.8%) |
| Mar 2007 | - | -$19.70 K(-96.4%) | -$230.20 K(+68.4%) |
| Dec 2006 | -$135.20 K(-135.3%) | -$540.90 K(-337.7%) | -$136.70 K(-125.1%) |
| Sept 2006 | - | $227.60 K(+121.4%) | $543.90 K(+18.8%) |
| June 2006 | - | $102.80 K(+39.3%) | $457.80 K(+24.8%) |
| Mar 2006 | - | $73.80 K(-47.2%) | $366.90 K(-2.7%) |
| Dec 2005 | $382.60 K(+94.4%) | $139.70 K(-1.3%) | $377.10 K(+2.1%) |
| Sept 2005 | - | $141.50 K(+1089.1%) | $369.50 K(+27.8%) |
| June 2005 | - | $11.90 K(-85.8%) | $289.20 K(-3.8%) |
| Mar 2005 | - | $84.00 K(-36.4%) | $300.70 K(+19.8%) |
| Dec 2004 | $196.80 K(+13.4%) | $132.10 K(+115.8%) | $251.10 K(+38.5%) |
| Sept 2004 | - | $61.20 K(+161.5%) | $181.30 K(+21.7%) |
| June 2004 | - | $23.40 K(-32.0%) | $149.00 K(-16.0%) |
| Mar 2004 | - | $34.40 K(-44.8%) | $177.30 K(+7.3%) |
| Dec 2003 | $173.50 K(+73.7%) | $62.30 K(+115.6%) | $165.20 K(+13.9%) |
| Sept 2003 | - | $28.90 K(-44.1%) | $145.00 K(-0.3%) |
| June 2003 | - | $51.70 K(+131.8%) | $145.50 K(+25.0%) |
| Mar 2003 | - | $22.30 K(-47.0%) | $116.40 K(+16.5%) |
| Dec 2002 | $99.90 K(+2.6%) | $42.10 K(+43.2%) | $99.90 K(+87.4%) |
| Sept 2002 | - | $29.40 K(+30.1%) | $53.30 K(+25.4%) |
| June 2002 | - | $22.60 K(+289.7%) | $42.50 K(-26.6%) |
| Mar 2002 | - | $5800.00(-228.9%) | $57.90 K(-40.6%) |
| Dec 2001 | $97.40 K(-37.8%) | -$4500.00(-124.2%) | $97.40 K(-50.2%) |
| Sept 2001 | - | $18.60 K(-51.1%) | $195.70 K(-8.5%) |
| June 2001 | - | $38.00 K(-16.1%) | $213.80 K(+12.1%) |
| Mar 2001 | - | $45.30 K(-51.7%) | $190.80 K(+22.0%) |
| Dec 2000 | $156.50 K(+1122.7%) | $93.80 K(+155.6%) | $156.40 K(+155.6%) |
| Sept 2000 | - | $36.70 K(+144.7%) | $61.20 K(+68.6%) |
| June 2000 | - | $15.00 K(+37.6%) | $36.30 K(+18.2%) |
| Mar 2000 | - | $10.90 K(-878.6%) | $30.70 K(+147.6%) |
| Dec 1999 | $12.80 K(-230.6%) | -$1400.00(-111.9%) | $12.40 K(-10.1%) |
| Sept 1999 | - | $11.80 K(+25.5%) | $13.80 K(+590.0%) |
| June 1999 | - | $9400.00(-227.0%) | $2000.00(-127.0%) |
| Mar 1999 | - | -$7400.00 | -$7400.00 |
| Dec 1998 | -$9800.00(-22.8%) | - | - |
| Dec 1997 | -$12.70 K(-117.0%) | - | - |
| Dec 1996 | $74.50 K(+106.4%) | - | - |
| Dec 1995 | $36.10 K(+5.6%) | - | - |
| Dec 1994 | $34.20 K(-19.7%) | - | - |
| Dec 1993 | $42.60 K | - | - |
FAQ
- What is TherapeuticsMD annual earnings before interest & taxes?
- What is the all time high annual EBIT for TherapeuticsMD?
- What is TherapeuticsMD annual EBIT year-on-year change?
- What is TherapeuticsMD quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for TherapeuticsMD?
- What is TherapeuticsMD quarterly EBIT year-on-year change?
- What is TherapeuticsMD TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for TherapeuticsMD?
- What is TherapeuticsMD TTM EBIT year-on-year change?
What is TherapeuticsMD annual earnings before interest & taxes?
The current annual EBIT of TXMD is -$8.52 M
What is the all time high annual EBIT for TherapeuticsMD?
TherapeuticsMD all-time high annual earnings before interest & taxes is $11.86 M
What is TherapeuticsMD annual EBIT year-on-year change?
Over the past year, TXMD annual earnings before interest & taxes has changed by -$19.19 M (-179.93%)
What is TherapeuticsMD quarterly earnings before interest & taxes?
The current quarterly EBIT of TXMD is -$564.00 K
What is the all time high quarterly EBIT for TherapeuticsMD?
TherapeuticsMD all-time high quarterly earnings before interest & taxes is $58.04 M
What is TherapeuticsMD quarterly EBIT year-on-year change?
Over the past year, TXMD quarterly earnings before interest & taxes has changed by +$850.00 K (+60.11%)
What is TherapeuticsMD TTM earnings before interest & taxes?
The current TTM EBIT of TXMD is -$4.90 M
What is the all time high TTM EBIT for TherapeuticsMD?
TherapeuticsMD all-time high TTM earnings before interest & taxes is $52.00 M
What is TherapeuticsMD TTM EBIT year-on-year change?
Over the past year, TXMD TTM earnings before interest & taxes has changed by -$56.90 M (-109.42%)